SRL
MXCT icon

Scientech Research LLC’s MaxCyte MXCT Stock Holding History

Scientech Research LLC’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.84K Sell
12,580
-57
-0.5% -$53 0.01% 446
2025
Q4 		$19.6K Buy
+12,637
New +$20.2K 0.01% 467

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Scientech Research LLC's MXCT Position: Q1 2026 in Review

Scientech Research LLC reduced its MaxCyte (MXCT) stake by 0.45% in Q1 2026, selling an estimated $53 and leaving 12,580 shares worth $8.84K. The position accounts for 0.01% of the portfolio, ranked #446.

Scientech Research LLC first reported a position in MXCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $19.6K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Scientech Research LLC held 12,580 shares of MaxCyte worth $8.84K as of Q1 2026.
  • Scientech Research LLC sold 57 MaxCyte shares in Q1 2026, an estimated $53.
  • MaxCyte made up 0.01% of Scientech Research LLC's portfolio in Q1 2026, its #446 holding.
  • Scientech Research LLC first reported a position in MaxCyte in Q4 2025 and has held it in 2 quarters since.
  • Scientech Research LLC's MaxCyte position peaked at $19.6K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.